SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells

Oncology Letters

Volumn 8, Issue 1, 2014, Pages 367-373

  Liu, Ying ^a   Zhu, Zuan ^a   Cai, Hongxing ^a   Liu, Qinghua ^a   Zhou, Honglian ^a   Zhu, Zhengqiu ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

4 4 (4 chloro phenyl) thiazol 2 ylamino phenol; Glutathione; Glutathione S transferase; Mitogen activated protein kinase pathway; SGC7901 DDP cells; Sphingosine kinase 1

Indexed keywords

4 [4 (4 CHLORO PHENYL) THIAZOL 2 YLAMINO] PHENOL; CISPLATIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; PHENOL DERIVATIVE; PHOSPHORYLATED C JUN AMINO TERMINAL KINASE; PHOSPHORYLATED EXTRACELLULAR SIGNAL REGULATED KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84901241655     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2083     Document Type: Article

References (29)

1. Lekakis L, Tryfonopoulos D, Pistamatzian N, et al: Salvage chemotherapy with cisplatin and 5-fluorouracil in metastatic breast cancer. Particular activity against liver metastases. Anticancer Res 32: 1833-1837, 2012.
2. García-Velasco A, Durán I, García E, et al: Biological markers of cisplatin resistance in advanced testicular germ cell tumours. Clin Transl Oncol 14: 452-457, 2012.
3. Yanagawa M, Tatsumi M, Miyata H, et al: Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors. J Nucl Med 53: 872-880, 2012.
4. Kumar A and Saba JD: Lyase to live by: sphingosine phosphate lyase as a therapeutic target. Expert Opin Ther Targets 13: 1013-1025, 2009.
5. Hla T: Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15: 513-520, 2004.
6. Ogretmen B and Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4: 604-616, 2004.
7. Spiegel S and Milstien S: Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 277: 25851-25854, 2002.
8. Taha, TA, Argraves KM and Obeid LM: Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim Biophys Acta 1682: 48-55, 2004.
9. Kumar A, Wessels D, Daniels KJ, et al: Sphingosine-1-phosphate plays a role in the suppression of lateral pseudopod formation during Dictyostelium discoideum cell migration and chemotaxis. Cell Motil Cytoskeleton 59: 227-241, 2004.
10. Oskouian B and Saba JD: Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate. Semin Cell Dev Biol 15: 529-540, 2004.
11. Spiegel S, English D and Milstien S: Sphingosine 1-phosphate signaling: providing cells with a sense of direction. Trends Cell Biol 12: 236-242, 2002.
12. French KJ, Upson JJ, Keller SN, et al: Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 318: 596-603, 2006.
13. Roukos DH and Kappas AM: Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2: 98-107, 2005.
14. Menges M, Schmidt C, Lindemann W, et al: Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate. J Cancer Res Clin Oncol 129: 423-429, 2003.
15. Zhao Z, Wang J, Tang J, et al: JNK-and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells. Biochem J 444: 291-301, 2012.
16. Hasegawa M, Ishiguro K, Ando T and Goto H: Geranylgeranylacetone attenuates cisplatin-induced reductions in cell viability by suppressing the elevation of intracellular p53 content without heat shock protein induction. Nagoya J Med Sci 74: 123-131, 2012.
17. Vasconcelos FC, Cavalcanti GB Jr, Silva KL, et al: Constrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice. Leuk Res 31: 445-454, 2007.
18. Patel NH and Rothenberg ML: Multidrug resistance in cancer chemotherapy. Invest New Drugs 12: 1-13, 1994.
19. Legrand O, Simonin G, Beauchamp-Nicoud A, et al: Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood 94: 1046-1056, 1999.
20. Valko M, Rhodes CJ, Moncol J, et al: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40, 2006.
21. Cobb MH and Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
22. Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549, 2009.
23. Lee HG, Minematsu H, Kim KO, et al: Actin and ERK1/2-CEBPβ signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells. Biomaterials 32: 9197-9206, 2011.
24. McGlynn LM, Kirkegaard T, Edwards J, et al: Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients. Clin Cancer Res 15: 1487-1495, 2009.
25. Atmaca A, Pauligk C, Steinmetz K, et al: Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology 80: 130-134, 2011.
26. Wasserman WW and Fahl WE: Functional antioxidant responsive elements. Proc Natl Acad Sci USA 94: 5361-5366, 1997.
27. Li Y and Jaiswal AK: Regulation of human NAD(P)H: quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 267: 15097-15104, 1992.
28. Rushmore TH and Pickett CB: Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J Biol Chem 265: 14648-14653, 1990.
29. Prestera T, Holtzclaw WD, Zhang Y and Talalay P: Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 90: 2965-2969, 1993.